Related Experiment Video
Updated: Dec 20, 2025

Unilateral Ureteral Obstruction Model for Investigating Kidney Interstitial Fibrosis
Published on: April 25, 2025
Longitudinal kidney injury biomarker trajectories in children with obstructive uropathy
Daryl J McLeod1,2, Yuri V Sebastião3, Christina B Ching4,5
1Section of Urology, Nationwide Children's Hospital, Columbus, OH, 43205, USA. Daryl.mcleod@nationwidechildrens.org.
Insights
In children with obstructive uropathy (OU), plasma neutrophil gelatinase-associated lipocalin (pNGAL) and urine liver-type fatty acid-binding protein (uL-FABP) levels increased over time, indicating potential for risk stratification in pediatric kidney disease.
Area of Science:
- Pediatric Nephrology
- Biomarker Discovery
- Urology
Background:
- Congenital obstructive uropathy (OU) is a primary cause of kidney failure in children.
- Renal tubular injury from stretch and ischemia is a key mechanism in OU.
- Tubular injury biomarkers may enhance risk assessment for OU patients.
Purpose of the Study:
- To investigate the utility of urinary and plasma biomarkers in stratifying risk for pediatric obstructive uropathy.
- To compare levels of neutrophil gelatinase-associated lipocalin (NGAL), interleukin-18 (IL-18), and liver-type fatty acid-binding protein (L-FABP) in children with and without kidney replacement therapy (KRT).
Main Methods:
- Patients from the CKiD study with OU were categorized into cases (receiving KRT) and controls (KRT-free).
- Urine and plasma NGAL, IL-18, and L-FABP levels were measured at baseline and annually.
- Urine biomarker values were normalized to urine creatinine.
Main Results:
- No significant differences in biomarkers were observed at enrollment between cases and controls.
- Plasma NGAL and urine L-FABP/creatinine levels significantly increased annually in cases but remained stable in controls.
- These findings persisted even after adjusting for baseline glomerular filtration rate (GFR).
Conclusions:
- Plasma NGAL and urine L-FABP levels rise in the 5 years preceding KRT in children with OU, independent of baseline GFR.
- These biomarkers show promise for predicting outcomes in pediatric obstructive uropathy.
- Further research is needed to establish optimal cutoff values and compare their efficacy against existing clinical predictors.
Background:
Congenital obstructive uropathy (OU) is a leading cause of pediatric kidney failure, representing a unique mechanism of injury, in part from renal tubular stretch and ischemia. Tubular injury biomarkers have potential to improve OU-specific risk stratification.
Methods:
Patients with OU were identified in the Chronic Kidney Disease in Children (CKiD) study. "Cases" were defined as individuals receiving any kidney replacement therapy (KRT), while "controls" were age- and time-on-study matched and KRT free at last study visit. Urine and plasma neutrophil gelatinase-associated lipocalin (NGAL), interleukin 18 (IL-18), and liver-type fatty acid-binding protein (L-FABP) levels were measured at enrollment and annually and compared between cases and controls. Urine values were normalized to urine creatinine.
Results:
In total, 22 cases and 22 controls were identified, with median (interquartile range) ages of 10.5 (9.0-13.0) and 15.9 (13.9-16.9) years at baseline and outcome, respectively. At enrollment there were no differences noted between cases and controls for any urine (u) or plasma (p) biomarker measured. However, the mean pNGAL and uL-FABP/creatinine increased throughout the study period in cases (15.38 ng/ml per year and 0.20 ng/ml per mg/dl per year, respectively, p = 0.01 for both) but remained stable in controls. This remained constant after controlling for baseline glomerular filtration rate (GFR).
Conclusions:
In children with OU, pNGAL and uL-FABP levels increased over the 5 years preceding KRT; independent of baseline GFR. Future studies are necessary to identify optimal cutoff values and to determine if these markers outperform current clinical predictors.
Related Concept Videos
Acute Kidney Injury III: Clinical Manifestations
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Acute Kidney Injury II: Pathophysiology
Acute Kidney Injury I: Introduction
Chronic Kidney Disease I: Introduction
Urinary Tract Calculi II: Pathophysiology and Clinical Manifestations

